Highline Wealth Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2K Buy
39
+8
+26% +$3.38K ﹤0.01% 448
2026
Q1
$14.7K Buy
31
+6
+24% +$3.02K ﹤0.01% 362
2025
Q4
$11.7K Buy
25
+12
+92% +$5.57K ﹤0.01% 364
2025
Q3
$5.54K Sell
13
-1
-7% -$388 ﹤0.01% 550
2025
Q2
$5.36K Buy
14
+1
+8% +$360 ﹤0.01% 432
2025
Q1
$4.49K Buy
13
+5
+63% +$1.61K ﹤0.01% 449
2024
Q4
$2.4K Buy
8
+4
+100% +$1.4K ﹤0.01% 432
2024
Q3
$1.63K Buy
4
+3
+300% +$1.1K ﹤0.01% 469
2024
Q2
$321 Buy
+1
New +$325 ﹤0.01% 524

Other funds holding HCA

Highline Wealth Partners's HCA Position: Q2 2026 in Review

Highline Wealth Partners increased its HCA Healthcare (HCA) stake by 26% in Q2 2026, buying an estimated $3.38K and bringing the position to 39 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #448.

Highline Wealth Partners first reported a position in HCA in Q2 2024 and has held it in 9 quarters since. 216 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Highline Wealth Partners held 39 shares of HCA Healthcare worth $15.2K as of Q2 2026.
  • Highline Wealth Partners bought 8 HCA Healthcare shares in Q2 2026, an estimated $3.38K.
  • HCA Healthcare made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #448 holding.
  • Highline Wealth Partners first reported a position in HCA Healthcare in Q2 2024 and has held it in 9 quarters since.
  • 216 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.